Key Data:
GARFIELD-AF provides assessments on unselected population groups who are followed for a minimum of 2 years and a maximum of 8 years. Persistence with ongoing anticoagulant therapy is being evaluated using the following parameters.
- Rate of discontinuation
- Duration of time on therapy
- Reasons for discontinuation
Key Publications:
Kakkar AJ et al (2012) International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J, 163, 13-19